Jubilant Bhartia Group to open state of the art facility in Genome Valley
The announcement was made after Industries Minister KT Rama Rao met with Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group at BioAsia 2023.
Hyderabad: The State government’s flagship event, BioAsia 2023, is turning out to be a continuation of the trend witnessed during the World Economic Forum in Davos, when several prominent global firms came forward to announce their investment plans and expansion projects in Telangana.
Apart from pharma major Bristol Myers Squibb, vaccine maker Sanofi and multinational conglomerate Welspun, who announced their Telangana plans earlier this week, global pharma and Life Sciences major Jubilant Bhartia Group announced on Saturday that it would establish a state-of-the-art facility at Genome Valley in Hyderabad.
Also Read
The announcement was made after Industries Minister KT Rama Rao met with Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group at the BioAsia 2023 event here.
“I am delighted that Jubilant Group, a global leader in pharma will soon set up a state-of-the-art facility at Genome Valley, Hyderabad. Jubilant’ s entry into Hyderabad is a testament to the city’s vibrant ecosystem, extraordinary infrastructure and rich talent pool that drives innovation,” Rama Rao said.
He said that with the entry of Jubilant, Hyderabad would now host all major CROs in India and that the city had emerged as the ‘Life sciences Research Capital’ of the country. The Telangana Government was committed to providing full support and cooperation to the group to help them grow organically within the State, he said.
Strongly endorsing Hyderabad as an investment destination, Hari S Bhartia said that over the last few years, Hyderabad had become a centre for biotechnology and life sciences, bringing in a great deal of investment from industry.
“It provides a favourable ecosystem for developing biotechnology and life sciences businesses, with a wide variety of qualified talent pools, world-class infrastructure and business-friendly government. As a result, many prominent businesses have established themselves in Hyderabad. Jubilant Biosys will explore setting up a state of art facility in Genome Valley in Hyderabad in the near future,” he said after participating in a panel discussion on Friday along with the Minister at the BioAsia venue.
With the addition of the Jubilant Group, Hyderabad’s status as a hub for Clinical Research Organizations in India, has grown, with the city now hosting major global companies, including Eurofins, Curia, Sai Life Sciences, Aragen Life Sciences, Syngene International and others.
The Jubilant Bhartia Group, meanwhile, has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. It has four flagships companies- Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. Currently the group has a global workforce of around 46,000 employees.
